{"the anticoagulant activities increase": 28, "The risk or severity of bleeding and hemorrhage increase": 29, "The risk or severity of bleeding increase": 30, "The therapeutic efficacy increase": 31, "the anticoagulant activities decrease": 32, "The therapeutic efficacy decrease": 33, "The risk or severity of hemorrhage increase": -1, "the antiplatelet activities increase": -1, "The risk or severity of adverse effects increase": 34, "The risk or severity of hyponatremia increase": -1, "the antihypertensive activities decrease": 35, "The risk or severity of hypertension increase": 36, "the excretion rate which could result in a higher serum level decrease": 37, "the excretion rate which could result in a lower serum level and potentially a reduction in efficacy increase": 38, "the hypertensive activities increase": 39, "the immunosuppressive activities increase": 40, "The serum concentration increase": 41, "the nephrotoxic activities increase": -1, "The excretion decrease": 42, "The serum concentration decrease": 43, "the neurotoxic activities increase": 44, "an increase in the absorption resulting in an increased serum concentration and potentially a worsening of adverse effects cause": -1, "The metabolism increase": 45, "The metabolism decrease": 46, "a decrease in the absorption resulting in a reduced serum concentration and potentially a decrease in efficacy cause": 47, "The risk or severity of myelosuppression increase": -1, "The risk or severity of renal failure increase": -1, "The risk or severity of hyperkalemia increase": 48, "The risk or severity of nephrotoxicity increase": -1, "The risk or severity of liver damage increase": -1, "The risk or severity of renal failure and hypertension increase": -1, "The risk or severity of myopathy rhabdomyolysis and myoglobinuria increase": 49, "The risk or severity of seizure increase": -1, "the hepatotoxic activities increase": -1, "The risk or severity of hypokalemia increase": 50, "the central nervous system depressant ( CNS depressant ) activities increase": 51, "the sedative activities increase": 52, "the serotonergic activities increase": 53, "The risk or severity of serotonin syndrome increase": 54, "The risk or severity of CNS depression increase": -1, "The risk or severity of sedation increase": 55, "The risk or severity of hypoglycemia increase": 56, "the thrombogenic activities increase": -1, "The risk or severity of neutropenia increase": -1, "The risk or severity of QTc prolongation increase": 57, "The risk or severity of gastrointestinal bleeding increase": 58, "The risk or severity of hypotension increase": 59, "The risk or severity of orthostatic hypotension and syncope increase": -1, "The risk or severity of hypotension and orthostatic hypotension increase": -1, "the hypotensive activities increase": 60, "the antihypertensive activities increase": -1, "The risk or severity of renal failure hyperkalemia and hypertension increase": 61, "The risk or severity of renal failure hypotension and hyperkalemia increase": -1, "the hyperkalemic activities increase": -1, "The risk or severity of angioedema increase": -1, "the orthostatic hypotensive activities increase": 62, "the neuromuscular blocking activities increase": 63, "the bradycardic activities increase": 64, "the neuromuscular blocking activities decrease": -1, "The risk or severity of hyperglycemia increase": 65, "The risk or severity of tendinopathy increase": 66, "the hypokalemic activities increase": -1, "The risk or severity of fluid retention increase": -1, "The risk or severity of gastrointestinal irritation increase": -1, "The risk or severity of myopathy and weakness increase": -1, "The risk or severity of edema formation increase": 67, "The risk or severity of electrolyte imbalance increase": -1, "the anticholinergic activities increase": -1, "the analgesic activities increase": -1, "the sedative and stimulatory activities decrease": -1, "the stimulatory activities decrease": -1, "the hypoglycemic activities increase": 68, "The risk or severity of Tachycardia increase": 69, "The risk or severity of extrapyramidal symptoms increase": -1, "The risk or severity of sedation and somnolence increase": -1, "The risk or severity of hypertension decrease": -1, "the vasoconstricting activities increase": 70, "the arrhythmogenic activities increase": 71, "The risk or severity of bradycardia increase": 72, "The risk or severity of QTc prolongation decrease": -1, "the QTcprolonging activities increase": 73, "The risk or severity of neutropenia and thrombocytopenia increase": -1, "The risk or severity of hyperthermia and oligohydrosis increase": -1, "the hypoglycemic activities decrease": -1, "The serum concentration of the active metabolites increase": -1, "The risk or severity of QTc prolongation and hypotension increase": -1, "The risk or severity of Cardiac Arrhythmia increase": -1, "The risk or severity of hypotension dyspepsia and headache increase": -1, "the vasodilatory activities increase": 74, "The risk or severity of Tachycardia and drowsiness increase": -1, "The absorption decrease": -1, "the vasopressor activities increase": -1, "the hypertensive and vasoconstricting activities increase": -1, "the tachycardic activities increase": -1, "the neuroexcitatory activities increase": 75, "The protein binding decrease": 76, "the orthostatic hypotensive hypotensive and antihypertensive activities increase": 77, "The risk or severity of methemoglobinemia increase": -1, "The risk or severity of hypotension and CNS depression increase": -1, "the bronchodilatory activities decrease": -1, "DRUGBANK::carrier::Compound:Gene": 3, "DRUGBANK::enzyme::Compound:Gene": 2, "DRUGBANK::target::Compound:Gene": 1, "Hetionet::CbG::Compound:Gene": 11, "Hetionet::CdG::Compound:Gene": 23, "Hetionet::CuG::Compound:Gene": 12}